IPO
Proceeds to fund multi-centre study of STAR Mapping to improve outcomes of persistent Atrial Fibrillation treatment
Lightcast Discovery Ltd announces that it has raised £1.3 m in seed financing from private investors to develop the capabilities and applications of its platform including continuing to expand its range of pilot studies.
4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final close
ADC Therapeutics SA announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common shares.
To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM
Bordeaux, France, September 05th 2019 – LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery, announced that it has raised €6.2 million via a capital increase and non-dilutive funding.
BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator.
TreeFrog Therapeutics, an expert stem cell company, announces that it has received close to €3M in non-dilutive funding from French and European programs.
Acacia Pharma Group plc announces its unaudited interim results for the six-month period ended 30 June 2019.
Polyphor AG announced that the company will present at the 21st Annual H.C. Wainwright Global Investment Conference, taking place September 8-10, 2019 in New York City.
PRESS RELEASES